A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Aristotle University Of Thessaloniki
Brain Inflammation Collaborative
Reveal Pharmaceuticals Inc.
Fondazione Don Carlo Gnocchi Onlus
The Cleveland Clinic